Track Overview
This page is designed to provide a short description of the topics you will find in each track. To view all panels from last year, Click Here.
AdvaMed 2010 Program Tracks:
- 21st Century Healthcare
- Business Development & Finance
- Compliance Best Practices
- Emerging Company Issues
- Executive Workshops
- Hot Technologies: The Latest in MedTech
- Legal & Intellectual Property
- Quality
- Regulatory
- Reimbursement
This track addresses the latest policy developments in the U.S. and internationally.
Previous topics include:
- Organizing to Capture Value in an Evidence-Driven Environment
- Get Ready for Healthcare Reform
- Can Innovation Thrive in a Healthcare System focused on both Clinical and Cost Effectiveness?
- Balancing on the Edge: Managing the Dynamics of Risk, Innovation, and Globalization
Business Development / Finance
This track appeals to emerging company executives, business development professionals, venture, angel and other financial related professionals by addressing both business development and capital formation issues.
Previous topics include:
- Getting on the MAP: Messaging And Positioning Towards Negotiations
- Have we been here before? A current and future look at the medtech M&A market
- Pulse of the industry: Global medical technology report 2009
- Traditional and Alternative Methods of Financing Your Medical Device Company
- Looking Out Ahead: Critical Issues to Consider when Entering an M&A Transaction
Sessions in this track address both the issues faced by larger, global companies with products and sales as well as what smaller companies with a future product launch need to know.
Previous topics include:
- Minimizing Risks in Contractual Arrangements with Physician Consultants and Clinical Investigators
- Putting the Code into Effect
- Use of Distributors in the Promotional Process - Managing the Risks
- The Case for Better Compliance in the Downturn
Previous topics include:
- Tap Into Nearly $2B Government Funding for Innovative Medical Technology
- Shining a Light on Payments to Physicians
- Partnering between Large & Small Diagnostics Companies
- What Emerging Companies Must Know: Product Approval, Coverage, Coding, Reimbursement
- The Insider's View on Medical Device Investing: Perspectives from Private Equity, Venture Capital, and Other Institutional Investors
Based on space availability, we are able to feature up to four Executive Workshops (two hours each). The workshops are designed to be hands-on and provide “how to” information for our audience.
Examples of successful workshops include the following:
- Bringing Medical Devices to the U.S. Market
- Strategies for Developing and Maintaining Compliant Industry-Referral Source Relationships
- Dangerous Documents: Avoiding Land Mines in FDA Records and Emails
- Crisis Prevention & Risk Mitigation 101: 5 Things Every Company Must Be Prepared For
Hot Technologies: The Latest in MedTech
This track examines the latest technology advances by area. Panels address what’s new, future trends and current/future issues. Areas we expect to feature include the following:
- Advanced wound care
- Blood & related technologies
- Cardiovascular
- Diagnostic imaging
- In-Vitro Diagnostics
- Ophthalmology
- Orthopedics
- Women’s Health
Previous topics include:
- Surgical Robotic Technology- How Far and How Fast
- Moving medical devices into the home
- Point of Care Diagnostics: Decentralizing the Healthcare Paradigm
- Technology’s Role in Improving Medical Care and Reducing Treatment Costs
- The Future of Innovation in Cardiovascular Disease Treatments
This track examines the legal and intellectual property issues impacting medical device companies today and in the future.
Previous topics include:
- Industry-Provider Interactions: An Innovative Approach to Meeting Current Compliance Challenges
- How to Protect Consumers while Encouraging Innovation: The Federal Preemption Debate
- New Trends in Medical Device Fraud and Abuse/Off-Label Promotion Enforcement
- Still Exposed? Legislative and Product Liability Risks for PMA Devices
Because quality is critical to the design and manufacturer of every medical device, we expect to feature panels that will provide timely, critical and relevant information to both the device companies that are already marketing their product as well as those who are looking to market in the future.
Previous topics include:
- Quality in the Global Supply Chain
- Getting More Value from Your Medical Devices After the Sale
The regulatory track offers informative and instructive panels designed to engage both senior level regulatory affairs professionals and members of their staff. We envision this track to be a unique opportunity for executives from all sectors to interact with senior members of the Food & Drug Administration as well as other international regulatory authorities.
Previous topics include:
- Diagnostics - The Wave of the Future
- Unique Device Identification: Change is Coming
- 510(k) Reform: FDA, Hill and Industry Perspectives
- Creating an Impactful DTC Marketing Campaign in Today's Changing Environment
- Navigating the Opportunities – and Avoiding the Pitfalls – in China’s New Healthcare Reform Plan
- The Value and Challenges of Device Registries
Previous topics include:
- CMS and Commercial Payer Coverage and Reimbursement Strategies for Market Launch Success
- How Will Comparative Effectiveness Impact Medical Device Companies, What Are the Real World Impacts on the Bottom Line, and What Should Companies Be Doing?
- CMS in the Era of Healthcare Reform